Glaukos Corporation - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
GKOS New York 3840 www.glaukos.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Glaukos Corporation

Earnings Preview: Mettler-Toledo (MTD) Q1 Earnings Expected to Decline - Apr 24th, 2025 2:01 pm
Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Apr 23rd, 2025 2:01 pm
Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - Apr 23rd, 2025 11:00 am
Glaukos Announces the Release of its 2024 Sustainability Report - Apr 16th, 2025 11:00 am
Strength Seen in Veracyte (VCYT): Can Its 13.0% Jump Turn into More Strength? - Apr 10th, 2025 1:04 pm
Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30 - Apr 9th, 2025 11:00 am
What Makes Glaukos Corporation (GKOS) a Compelling Stock? - Apr 8th, 2025 1:41 pm
The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals - Apr 1st, 2025 2:49 pm
3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space - Mar 31st, 2025 1:10 pm
Breakeven On The Horizon For Glaukos Corporation (NYSE:GKOS) - Mar 24th, 2025 1:11 pm
Here's Why You Should Retain Glaukos Stock in Your Portfolio - Mar 13th, 2025 9:52 am
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution - Mar 11th, 2025 11:00 am
Is Glaukos Corporation (GKOS) the Best Medical Technology Stock to Buy According to Analysts? - Mar 5th, 2025 4:52 am
GKOS Crashes Almost 25% After Q4 Earnings: How to Play the Stock? - Feb 28th, 2025 2:43 pm
Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™ - Feb 24th, 2025 12:00 pm
We're Not Worried About Glaukos' (NYSE:GKOS) Cash Burn - Feb 23rd, 2025 1:58 pm
Wingstop Stock’s Dip Is an Opportunity, Analyst Says. Plus, Devon Energy, Cadence Design, and More. - Feb 22nd, 2025 12:47 am
GKOS Stock Falls Despite Q4 Earnings & Revenue Beat, Margins Decline - Feb 21st, 2025 1:40 pm
Glaukos Corp (GKOS) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Growth Amid ... - Feb 21st, 2025 7:15 am
Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates - Feb 20th, 2025 10:40 pm